Bernie Sanders thinks this $89,000-a-year drug should be $1,000 a year By: MarketWatch March 22, 2017 at 16:05 PM EDT Two lawmakers wrote to PTC Therapeutics Wednesday asking for about the controversial drug’s price tag. Read More >> Related Stocks: AbbVie Ptc Therapeutics